Purification of C1 Esterase Inhibitor from Human Plasma.

Authors: Verma, Sachin¹ (AUTHOR), Makadia, Savan¹ (AUTHOR), Dolia, Sheetal¹ (AUTHOR), Pawar, Amit¹ (AUTHOR), Kumar, Narendra² (AUTHOR) narendra.kumar@iar.ac.in

Source: Plasmatology. 12/26/2024, p1-7. 7p.

Subject Terms: *RESEARCH funding, *PROTHROMBIN time, *COMPLEMENT (Immunology), *BLOOD coagulation factors, *BLOOD plasma, *GENETIC disorders, *ION exchange resins, *ANGIONEUROTIC edema, *ANALYTICAL chemistry techniques, *CHROMATOGRAPHIC analysis, *BLOOD protein electrophoresis

ارزیابی تغییرات خون شناختی در بیماران مبتلا به فرم شدید کووید ۱۹ همراه با ترومبوآمبولیسم وریدی.

Alternate Title: Evaluation of hematological changes in critically ill COVID- 19 patients with venous thromboembolism.

Authors: اکبر هاشمی طیر¹ hashemiakbar@yahoo.com, مریم کامروان¹, محدثه مرادی پرست¹

Source: Pars Journal of Medical Sciences. Dec2024, Vol. 22 Issue 3, p30-36. 7p.

Subject Terms: *VEINS, *PROTHROMBIN time, *ENZYME-linked immunosorbent assay, *CATASTROPHIC illness, *BLOOD cell count, *PARTIAL thromboplastin time, *THROMBOEMBOLISM, *CASE-control method, *INTENSIVE care units, *FIBRINOGEN, *COVID-19, *DISEASE complications

Prothrombin time predicts steroid response in severe alcohol‐related hepatitis.

Authors: Tarli, Claudia¹ (AUTHOR), Mannucci, Sergio¹ (AUTHOR), Vecchione, Michele² (AUTHOR), Antonelli, Mariangela¹ (AUTHOR), Sestito, Luisa¹ (AUTHOR), Mancarella, Francesco Antonio¹ (AUTHOR), Tosoni, Alberto¹ (AUTHOR), Dionisi, Tommaso¹ (AUTHOR), Maccauro, Valeria¹ (AUTHOR), Sario, Giovanna Di¹ (AUTHOR), Burra, Patrizia³ (AUTHOR), Germani, Giacomo³ (AUTHOR), Gasbarrini, Antonio^4,5 (AUTHOR), Addolorato, Giovanni^1,5 (AUTHOR) giovanni.addolorato@unicatt.it

Source: Liver International. Mar2024, Vol. 44 Issue 3, p823-830. 8p.

Subject Terms: *PROTHROMBIN time, *HEPATITIS, *STEROID drugs, *LIVER transplantation, *ALCOHOL-induced disorders, *DRUNK driving, *SUFFERING

Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban.

Authors: Onelöv, Liselotte¹ (AUTHOR) liselotte.onelov@nordicbiomarker.com, Theodorsson, Elvar¹ (AUTHOR), Božič-Mijovski†, Mojca² (AUTHOR), Mavri, Alenka² (AUTHOR)

Source: Thrombosis Journal. 3/1/2024, Vol. 22 Issue 1, p1-8. 8p.

Subject Terms: *PROTHROMBIN time, *CLINICAL pathology, *ORAL drug administration, *ATRIAL fibrillation, *ANTICOAGULANTS, *TREATMENT effectiveness, *RIVAROXABAN, *T-test (Statistics), *COMPARATIVE studies, *DESCRIPTIVE statistics, *RESEARCH funding, *RECEIVER operating characteristic curves, *HEMORRHAGE

Consensus instability equations for routine coagulation tests.

Authors: Gómez Rioja, Rubén¹ (AUTHOR) rgrioja@salud.madrid.org, Caballero Garralda, Andrea² (AUTHOR), Comas Reixach, Immaculada² (AUTHOR), García Miralles, Carlos³ (AUTHOR), Llopis Díaz, María Antonia⁴ (AUTHOR), Martínez Espartosa, Débora⁵ (AUTHOR), Nicolás de Blas, Reyes⁶ (AUTHOR), Panadès Turró, Mariona⁷ (AUTHOR), Puigví Fernández, Laura⁸ (AUTHOR), Rodelgo Jiménen, Laura⁹ (AUTHOR), Sufrate-Vergara, Berta¹⁰ (AUTHOR), Ventura Orriols, Emma¹¹ (AUTHOR)

Source: Clinical Chemistry & Laboratory Medicine. Mar2025, p1. 12p. 2 Illustrations.

Subject Terms: *BLOOD coagulation tests, *PROTHROMBIN time, *STABILITY (Mechanics), *MEASUREMENT errors, *PARTIAL thromboplastin time, *MATHEMATICAL models, *BLOOD plasma

The effect of acetylcysteine on the prothrombin time and international normalized ratio: a narrative review.

Authors: Nazar, Messia¹ (AUTHOR), Kootstra-Ros, Jenny E.² (AUTHOR), Mian, Paola¹ (AUTHOR), Touw, Daniel J.^1,3 (AUTHOR), Sturkenboom, Marieke G. G.¹ (AUTHOR) m.g.g.sturkenboom@umcg.nl

Source: Clinical Toxicology (15563650). Mar2025, Vol. 63 Issue 3, p166-175. 10p.

Subject Terms: *ACETYLCYSTEINE, *PROTHROMBIN time, *INTERNATIONAL normalized ratio, *LIVER injuries, *ACETAMINOPHEN, *BLOOD coagulation factors, *MEDICAL research

An Observational Descriptive Study on The Significance of Serum Zinc Levels in Hepatic Cirrhosis Patients and Its Correlation with Child - Pughs Score in A Tertiary Care Hospital.

Authors: Krishnakumar, Ankith¹, Pugalendhi, Siddharth², Gaddam, Bhargav Kiran², K., Suganya³, suganyakavi1028@gmail.com, Appikatla, Tumbanatham⁴, Hanifah, Mohamed⁴

Source: European Journal of Cardiovascular Medicine; 2024, Vol. 14 Issue 4, p146-153, 8p

International council for standardisation in haematology recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of bleeding disorders.

Authors: Mackie, Ian¹ i.mackie@ucl.ac.uk, Casini, Alessandro², Pieters, Marlien^3,4, Pruthi, Rajiv⁵, Reilly‐Stitt, Chris⁶, Suzuki, Atsuo⁷

Source: International Journal of Laboratory Hematology. Feb2024, Vol. 46 Issue 1, p20-32. 13p.

Subject Terms: *HEMORRHAGE diagnosis, *PROTHROMBIN time, *PATHOLOGICAL laboratories, *HEMATOLOGY, *POINT-of-care testing, *MICROSCOPY, *GENETIC testing, *ANTICOAGULANTS, *FIBRINOGEN, *THROMBIN time, *HEPARIN

Citrus limon (L.) Osbeck Fruit Peel Extract Attenuates Carbon Tetrachloride-Induced Hepatocarcinogenesis in Sprague-Dawley Rats.

Authors: Boye, Alex¹ (AUTHOR), Asiamah, Ernest Amponsah² (AUTHOR), Martey, Orleans³ (AUTHOR), Ayertey, Frederick⁴ (AUTHOR)

Source: BioMed Research International. 1/2/2024, p1-15. 15p.

Subject Terms: *PROTHROMBIN time, *C-reactive protein, *ALPHA fetoproteins, *LIVER tumors, *ANIMAL experimentation, *HYDROCARBONS, *RATS, *LIVER diseases, *PHYTOCHEMICALS, *PLANT extracts, *LEMON, *BILIRUBIN

Poor Correlation of Rivaroxaban Concentration with the Routine Coagulation Screening Test in Chinese Patients with Atrial Fibrillation.

Authors: He, Jiake^1,2, Zhu, Bo¹, Shen, Yang^3,4, Hu, Jianping⁴, Hong, Kui^1,3,4

Source: Journal of Clinical Pharmacy & Therapeutics. 10/31/2023, p1-10. 10p.

Subject Terms: *RESEARCH, *PROTHROMBIN time, *STATISTICS, *PARTIAL thromboplastin time, *DIGOXIN, *BLOOD coagulation tests, *SCIENTIFIC observation, *PREDICTIVE tests, *LIQUID chromatography, *ATRIAL fibrillation, *BLOOD coagulation, *RIVAROXABAN, *DRUG interactions, *RESEARCH funding, *MASS spectrometry, *DESCRIPTIVE statistics, *THROMBIN time, *ROUTINE diagnostic tests, *STATISTICAL correlation, *INTERNATIONAL normalized ratio, *DATA analysis, *LONGITUDINAL method, *THIAZOLES, *PHARMACODYNAMICS

Geographic Terms: CHINA

The Effect of Sepsis and Septic Shock on the Viscoelastic Properties of Clot Quality and Mass Using Thromboelastometry: A Prospective Observational Study.

Authors: Mohapatra, Priyanka¹, Kumar, Arvind¹, Singh, Rakesh Kumar¹, Gupta, Ruchi² ruchi_gupta.mamc@yahoo.co.in, Hussain, Mumtaz¹, Singh, Swati¹, Kumar, Pankaj¹

Source: Indian Journal of Critical Care Medicine. Sep2023, Vol. 27 Issue 9, p625-634. 10p. 2 Diagrams, 10 Charts, 5 Graphs, 1 Map.

Subject Terms: *THROMBOSIS, *PROTHROMBIN time, *PARTIAL thromboplastin time, *BIOMARKERS, *BLOOD coagulation tests, *SCIENTIFIC observation, *THROMBELASTOGRAPHY, *MULTIPLE organ failure, *SEPSIS, *FIBRINOLYSIS, *PLATELET count, *FIBRINOGEN, *VISCOSITY, *SEPTIC shock, *LONGITUDINAL method

A Review of Thromboelastography for Nurses.

Authors: Vollmer, Nicholas J.¹ vollmer.nicholas@mayo.edu, Leshko, Nicole A.², Wilson Jr, Charles S.³, Gilbert, Brian W.⁴

Source: Critical Care Nurse. Jun2023, Vol. 43 Issue 3, p29-37. 9p. 1 Diagram, 2 Charts.

Subject Terms: *PROTHROMBIN time, *PARTIAL thromboplastin time, *ONLINE information services, *BLOOD coagulation tests, *SYSTEMATIC reviews, *CRITICALLY ill, *THROMBELASTOGRAPHY, *CONTINUING education units, *PATIENTS, *CRITICAL care nurses, *CATASTROPHIC illness, *DESCRIPTIVE statistics, *INTERNATIONAL normalized ratio, *MEDLINE, *CONTINUING education of nurses

Potential effects of carbamylation on the prothrombin time, activated partial thromboplastin time, and fibrinogen.

Authors: Mastella, Aline K.¹, de Carvalho, José A. M.¹, Pereira, Karla N.¹, das Neves, Yasmin S.¹, Stein, Carolina S.¹, Bochi, Guilherme V.², Moresco, Rafael N.¹ rnmoresco@ufsm.br

Source: International Journal of Laboratory Hematology. Feb2024, Vol. 46 Issue 1, p173-175. 3p.

Subject Terms: *PROTEIN metabolism, *PROTHROMBIN time, *PARTIAL thromboplastin time, *CHRONIC kidney failure, *UREA, *RISK assessment, *FIBRINOGEN, *INORGANIC compounds, *PEPTIDES, *DISEASE risk factors

Iodoacetamide blank compensation in FXIII functional assays: Is it still necessary?

Authors: Savard, Philippe¹ philippe.savard@chu-dijon.fr, Leguy‐Seguin, Vanessa², Chavy, Camille³, Genre‐Volot, Fabienne⁴, Callegarin, Anamaria⁴, Amiral, Jean⁵, Bonnotte, Bernard^2,6, Lecompte, Thomas^1,7, de Maistre, Emmanuel¹

Source: International Journal of Laboratory Hematology. Dec2023, Vol. 45 Issue 6, p969-971. 3p.

Subject Terms: *HEMORRHAGIC diseases, *PROTHROMBIN time, *INTRACRANIAL hemorrhage, *CATASTROPHIC illness, *BLOOD coagulation factors, *AMIDES, *PHENOTYPES

The magnitude and associated factors of coagulation abnormalities among liver disease patients at the University of Gondar Comprehensive Specialized Hospital Northwest, Ethiopia, 2022.

Authors: Melkamu, Abateneh¹ (AUTHOR) abatenehmelkamu@gmail.com, Woldu, Berhanu² (AUTHOR), Sitotaw, Chomaw² (AUTHOR), Seyoum, Masresha² (AUTHOR), Aynalem, Melak² (AUTHOR)

Source: Thrombosis Journal. 4/3/2023, Vol. 21 Issue 1, p1-11. 11p.

Subject Terms: *PROTHROMBIN time, *PARTIAL thromboplastin time, *ACADEMIC medical centers, *SPECIALTY hospitals, *VEGETABLES, *CROSS-sectional method, *FOOD consumption, *BLOOD transfusion, *LIVER diseases, *RISK assessment, *PHYSICAL activity, *BLOOD coagulation disorders, *ANEMIA, *EXERCISE, *SOCIODEMOGRAPHIC factors, *DISEASE risk factors, *DISEASE complications

Geographic Terms: ETHIOPIA

Cefoperazone-induced Coagulopathy in Critically Ill Patients Admitted to Intensive Care Unit.

Authors: Gudivada, Kiran Kumar¹ gkiran17medico@gmail.com, Krishna, Bhuvana¹, Sampath, Sriram¹

Source: Indian Journal of Critical Care Medicine. Mar2023, Vol. 27 Issue 3, p183-189. 7p. 1 Diagram, 2 Charts, 1 Graph.

Subject Terms: *INTENSIVE care units, *PROTHROMBIN time, *SCIENTIFIC observation, *CRITICALLY ill, *PATIENTS, *BLOOD coagulation, *DISEASE incidence, *VANCOMYCIN, *HOSPITAL care, *INTERNATIONAL normalized ratio, *CEFOPERAZONE, *VITAMIN K, *LONGITUDINAL method, *HEMORRHAGE, *BLOOD protein disorders

Bleeding and Bruising: Primary Care Evaluation.

Authors: Hughes, Pamela R., Lewis, Meghan N., Adams, Shalease S.

Source: American Family Physician; Nov2024, Vol. 110 Issue 5, p504-514, 11p

Diagnostic Potential of microRNA-122 for Stage Classification in Patients with HBV-Related Cirrhosis.

Authors: Qingqing Fang¹, Jin Liu¹, Wei Chen², Feng Li³, Shiyao Chen⁴, Ying Chen¹, chenying_1120@fudan.edu.cn

Source: Alternative Therapies in Health & Medicine; Nov2024, Vol. 30 Issue 11, p416-421, 6p

Some of the Non-Factor VIII Inhibitors Can Also Be Time-Dependent.

Authors: Chaonan Liu¹, Liqin Ling¹, Xunbei Huang¹, Juan Liao¹, Chuanmin Tao¹, Jing Zhou¹

Source: Archives of Pathology & Laboratory Medicine. Nov2024, Vol. 148 Issue 11, p1180-1181. 2p.

Subject Terms: *PROTHROMBIN time, *BLOOD coagulation factors, *PARTIAL thromboplastin time, *BLOOD plasma, *TIME, *CHEMICAL inhibitors

Coagulation Profile in Diabetes and Its Association with Diabetic Microvascular Complications.

Authors: Khan, Amna¹, Rauf, Abdul¹, Khan, Summaya¹, Sarfraz, Muhammad Haroon¹, Tarrar, Muhammad Shahid¹, Nisar, Maryam¹

Source: Pakistan Armed Forces Medical Journal. Feb2023, Vol. 73 Issue 1, p135-138. 4p.

Subject Terms: *DIABETIC retinopathy, *PROTHROMBIN time, *PARTIAL thromboplastin time, *TYPE 2 diabetes, *BLOOD coagulation, *GLYCEMIC index, *DIABETES, *THROMBELASTOGRAPHY

Geographic Terms: PAKISTAN